Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ivermectin and Colchicine in COVID-19
NCT05246072Phase 4Completed
- Sponsor
- Ain Shams University
- Start
- Nov 2021
- Primary completion
- Feb 2022
- Modality
- Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 4 trial of ivermectin, colchicine in coronavirus disease 2019 (COVID-19), sponsored by Ain Shams University. Started Nov 2021; status: completed.
02
Drugs
ivermectincolchicine
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05246072.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05246072.